Prestige Consumer Healthcare (NYSE:PBH) Stock Price Up 6.1%

Prestige Consumer Healthcare Inc (NYSE:PBH) shares were up 6.1% during mid-day trading on Wednesday . The stock traded as high as $36.81 and last traded at $36.80, approximately 738,800 shares changed hands during mid-day trading. An increase of 55% from the average daily volume of 475,658 shares. The stock had previously closed at $34.68.

Several equities analysts have recently issued reports on PBH shares. Zacks Investment Research upgraded Prestige Consumer Healthcare from a “sell” rating to a “hold” rating and set a $31.00 price target on the stock in a research note on Tuesday, May 28th. CIBC restated a “hold” rating and set a $84.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday, May 27th. TheStreet raised Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research note on Tuesday, July 23rd. Finally, ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Friday, July 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $61.07.

The firm’s fifty day moving average is $32.90 and its 200-day moving average is $30.52. The company has a market capitalization of $1.70 billion, a P/E ratio of 13.24, a price-to-earnings-growth ratio of 1.81 and a beta of 0.89. The company has a debt-to-equity ratio of 1.63, a quick ratio of 1.26 and a current ratio of 2.16.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.65 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.64 by $0.01. Prestige Consumer Healthcare had a negative net margin of 3.81% and a positive return on equity of 12.45%. The business had revenue of $232.15 million during the quarter, compared to the consensus estimate of $231.52 million. During the same quarter in the prior year, the firm earned $0.68 EPS. The firm’s revenue was down 8.6% compared to the same quarter last year. As a group, analysts expect that Prestige Consumer Healthcare Inc will post 2.82 EPS for the current fiscal year.

Several large investors have recently made changes to their positions in PBH. BlackRock Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 3.4% during the 2nd quarter. BlackRock Inc. now owns 6,455,495 shares of the company’s stock valued at $204,510,000 after acquiring an additional 214,690 shares in the last quarter. Vanguard Group Inc. raised its position in Prestige Consumer Healthcare by 0.7% in the second quarter. Vanguard Group Inc. now owns 4,898,276 shares of the company’s stock valued at $155,177,000 after purchasing an additional 32,075 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of Prestige Consumer Healthcare by 3.2% during the first quarter. Wells Fargo & Company MN now owns 2,299,827 shares of the company’s stock valued at $68,788,000 after purchasing an additional 71,275 shares in the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Prestige Consumer Healthcare by 2.2% during the first quarter. Champlain Investment Partners LLC now owns 2,088,940 shares of the company’s stock valued at $62,480,000 after purchasing an additional 44,975 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of Prestige Consumer Healthcare by 7.4% during the second quarter. Acadian Asset Management LLC now owns 1,483,625 shares of the company’s stock valued at $47,001,000 after purchasing an additional 102,314 shares in the last quarter.

About Prestige Consumer Healthcare (NYSE:PBH)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: What is the quiet period?

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.